[1] |
Chang LC, Haggstrom AN, Drolet BA, et al. Growth characteristics of infantile hemangiomas: implications for management[J]. Pediatrics, 2008,122(2):360⁃367. doi: 10.1542/ peds.2007⁃2767.
|
[2] |
Tollefson MM, Frieden IJ. Early growth of infantile hemangiomas: what parents′ photographs tell us[J]. Pediatrics, 2012,130(2):e314⁃e320. doi: 10.1542/peds.2011⁃3683.
|
[3] |
Haggstrom AN, Drolet BA, Baselga E, et al. Prospective study of infantile hemangiomas: clinical characteristics predicting complications and treatment[J]. Pediatrics, 2006,118(3):882⁃887. doi: 10.1542/peds.2006⁃0413.
|
[4] |
Amir J, Metzker A, Krikler R, et al. Strawberry hemangioma in preterm infants[J]. Pediatr Dermatol, 1986,3(4):331⁃332. doi: 10.1111/j.1525⁃1470.1986.tb00535.x.
|
[5] |
Powell TG, West CR, Pharoah PO, et al. Epidemiology of strawberry haemangioma in low birthweight infants[J]. Br J Dermatol, 1987,116(5):635⁃641. doi: 10.1111/j.1365⁃2133.1987. tb05896.x.
|
[6] |
Colonna V, Resta L, Napoli A, et al. Placental hypoxia and neonatal haemangioma: clinical and histological observations[J]. Br J Dermatol, 2010,162(1):208⁃209. doi: 10.1111/j.1365⁃2133.2009.09493.x.
|
[7] |
Doege C, Pritsch M, Frühwald MC, et al. An association between infantile haemangiomas and erythropoietin treatment in preterm infants[J]. Arch Dis Child Fetal Neonatal Ed, 2012,97(1):F45⁃49. doi: 10.1136/adc.2010.187344.
|
[8] |
Chen XD, Ma G, Chen H, et al. Maternal and perinatal risk factors for infantile hemangioma: a case⁃control study[J]. Pediatr Dermatol, 2013,30(4):457⁃461. doi: 10.1111/pde.12042.
|
[9] |
Anderson KR, Schoch JJ, Lohse CM, et al. Increasing incidence of infantile hemangiomas (IH) over the past 35 years: Correlation with decreasing gestational age at birth and birth weight[J]. J Am Acad Dermatol, 2016,74(1):120⁃126. doi: 10.1016/j.jaad.2015.08.024.
|
[10] |
Dickison P, Christou E, Wargon O. A prospective study of infantile hemangiomas with a focus on incidence and risk factors[J]. Pediatr Dermatol, 2011,28(6):663⁃669. doi: 10.1111/j.1525⁃1470.2011.01568.x.
|
[11] |
Hoornweg MJ, Smeulders MJ, Ubbink DT, et al. The prevalence and risk factors of infantile haemangiomas: a case⁃control study in the Dutch population[J]. Paediatr Perinat Epidemiol, 2012,26(2):156⁃162. doi: 10.1111/j.1365⁃3016.2011.01214.x.
|
[12] |
Mayer M, Minichmayr A, Klement F, et al. Tocolysis with the β⁃2⁃sympathomimetic hexoprenaline increases occurrence of infantile haemangioma in preterm infants[J]. Arch Dis Child Fetal Neonatal Ed, 2013,98(2):F108⁃111. doi: 10.1136/archdischild⁃2011⁃301030.
|
[13] |
Selmin A, Foltran F, Chiarelli S, et al. An epidemiological study investigating the relationship between chorangioma and infantile hemangioma[J]. Pathol Res Pract, 2014,210(9):548⁃553. doi: 10.1016/j.prp.2014.04.007.
|
[14] |
Castrén E, Salminen P, Gissler M, et al. Risk factors and morbidity of infantile haemangioma: preterm birth promotes ulceration[J]. Acta Paediatr, 2016,105(8):940⁃945. doi: 10. 1111/apa.13460.
|
[15] |
Hunjan MK, Schoch JJ, Anderson KR, et al. Prenatal risk factors for infantile hemangioma development[J]. J Invest Dermatol, 2017,137(4):954⁃957. doi: 10.1016/j.jid.2016.10.047.
|
[16] |
Schoch JJ, Hunjan MK, Anderson KR, et al. Temporal trends in prenatal risk factors for the development of infantile hemangiomas[J]. Pediatr Dermatol, 2018,35(6):787⁃791. doi: 10.1111/pde.13659.
|
[17] |
Smith C, Jones KL, Johnson DL, et al. Risk of infantile hemangiomas in the offspring of women with autoimmune disease and the pathogenic implications of these lesions[J]. Am J Med Genet A, 2018,176(3):570⁃577. doi: 10.1002/ajmg.a. 38594.
|
[18] |
Frieden IJ, Haggstrom AN, Drolet BA, et al. Infantile hemangiomas: current knowledge, future directions. Proceedings of a research workshop on infantile hemangiomas, April 7⁃9, 2005, Bethesda, Maryland, USA[J]. Pediatr Dermatol, 2005,22(5):383⁃406. doi: 10.1111/j.1525⁃1470.2005.00102.x.
|
[19] |
Kim EJ, Park HS, Yoon HS, et al. Maternal and perinatal factors of importance for occurrence and severity of infantile haemangioma[J]. Acta Derm Venereol, 2015,95(6):696⁃699. doi: 10.2340/00015555⁃2042.
|
[20] |
Itinteang T, Tan ST, Guthrie S, et al. A placental chorionic villous mesenchymal core cellular origin for infantile haemangioma[J]. J Clin Pathol, 2011,64(10):870⁃874. doi: 10.1136/jclinpath⁃2011⁃200191.
|
[21] |
North PE, Waner M, Mizeracki A, et al. GLUT1: a newly discovered immunohistochemical marker for juvenile hemangiomas[J]. Hum Pathol, 2000,31(1):11⁃22. doi: 10.1016/s0046⁃8177(00)80192⁃6.
|
[22] |
de Jong S, Itinteang T, Withers AH, et al. Does hypoxia play a role in infantile hemangioma?[J]. Arch Dermatol Res, 2016,308(4):219⁃227. doi: 10.1007/s00403⁃016⁃1635⁃x.
|
[23] |
Ritter MR, Reinisch J, Friedlander SF, et al. Myeloid cells in infantile hemangioma[J]. Am J Pathol, 2006,168(2):621⁃628. doi: 10.2353/ajpath.2006.050618.
|